Assessing Variability in Vascular Response to Cocoa With Personal Devices: A Series of Double-Blind Randomized Crossover n-of-1 Trials

被引:7
|
作者
Bapir, Mariam [1 ]
Campagnolo, Paola [2 ]
Rodriguez-Mateos, Ana [3 ]
Skene, Simon S. [1 ]
Heiss, Christian [1 ,4 ]
机构
[1] Univ Surrey, Fac Hlth & Med Sci, Dept Clin & Expt Med, Guildford, England
[2] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem Sci, Guildford, England
[3] Kings Coll London, Fac Life Sci & Med, Sch Life Course & Populat Sci, Dept Nutr Sci, London, England
[4] Surrey & Sussex NHS Healthcare Trust, Vasc Dept, Redhill, England
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
基金
英国经济与社会研究理事会;
关键词
cocoa flavanols; n-of-1; blood pressure; pulse wave velocity; variability; flow-mediated dilation; FLAVANOL-RICH COCOA; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; FLAVONOID INTAKE; ASSOCIATIONS; FLAVAN-3-OLS; AMLODIPINE; RISK;
D O I
10.3389/fnut.2022.886597
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Controlled clinical intervention studies have demonstrated that cocoa flavanols (CF) can decrease blood pressure and arterial stiffness in healthy humans, although a large variability in the effect size across trials has been reported. In this study, we evaluated the intra- and inter-individual variability of responses to CF in everyday life using a series of n-of-1 trials in healthy free-living individuals with normal blood pressure carrying personal devices. In total, eleven healthy young humans participated in a repeated crossover randomized controlled double-blind n-of-1 trial. On 8 consecutive days, each volunteer consumed on alternating days 6 CF capsules (862 mg CF) on 4 days and 6 matched placebo capsules (P, 0 mg CF/day) on another 4 days in one of the two randomized sequences (CF-P-CF-P-CF-P-CF-P or P-CF-P-CF-P-CF-P-CF). On each day, the capsules were taken at the same time in the morning with breakfast after baseline measurements. Each subject was provided with an upper arm blood pressure monitor and a finger clip that measures pulse wave velocity (PWV). Measurements of blood pressure, heart rate, and PWV were taken at least hourly over 12 h during the day by the participants. On the first 2 days, measurements were performed under supervision to provide training. The overall mixed model analysis showed that CF significantly decreased 12-h systolic blood pressure and PWV by -1.4 +/- 0.3 mmHg and -0.11 +/- 0.03 m/s, respectively. Peak effects were observed within the first 3 h (1.5 h SBP: -4.9 +/- 2.2 mmHg, PWV: -0.32 +/- 0.17 m/s) and again after 8 h post-ingestion. Large inter-individual variation in responses was found [intra-cluster correlation coefficients (ICC): 0.41, 0.41]. When analyzing single individuals' datasets, there was also considerable between-day variation in individual responses that varied greatly between subjects (ICC: 0-0.30, 0-0.22, 0-0.45). Effect sizes inversely correlated with baseline blood pressure values both between- and within-subjects. The data confirm that cocoa can decrease blood pressure and arterial stiffness in everyday life when elevated within the normal range. The large inter- and intra-individual variation in responses calls for more personalized nutritional intervention strategies.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study
    Tzounis, Xenofon
    Rodriguez-Mateos, Ana
    Vulevic, Jelena
    Gibson, Glenn R.
    Kwik-Uribe, Catherine
    Spencer, Jeremy P. E.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (01): : 62 - 72
  • [22] Effects on Peripheral and Central Blood Pressure of Cocoa With Natural or High-Dose Theobromine A Randomized, Double-Blind Crossover Trial
    van den Bogaard, Bas
    Draijer, Richard
    Westerhof, Berend E.
    van den Meiracker, Anton H.
    van Montfrans, Gert A.
    van den Born, Bert-Jan H.
    HYPERTENSION, 2010, 56 (05) : 839 - U242
  • [23] Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer
    Carpenter, Janet S.
    Storniolo, Anna Maria
    Johns, Shelley
    Monahan, Patrick O.
    Azzouz, Faouzi
    Elam, Julie L.
    Johnson, Cynthia S.
    Shelton, Richard C.
    ONCOLOGIST, 2007, 12 (01): : 124 - 135
  • [24] AN ANALYSIS OF TWO RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS ASSESSING THE EFFECT OF MILNACIPRAN FOR FIBROMYALGIA
    Geisser, M. E.
    Palmer, R. H.
    Wang, Y.
    Gendreau, R. M.
    Trifilo, M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 19 - 19
  • [25] Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study
    Nagai, Hiroki
    Kitano, Toshiyuki
    Nishimura, Takafumi
    Yasuda, Hiroyasu
    Nakata, Kazumi
    Takashima, Sachie
    Kanai, Masashi
    Matsumoto, Shigemi
    Mori, Yukiko
    Kakudo, Yuichi
    Sato, Hiroyasu
    Yamaguchi, Takuhiro
    Kameno, Kaoru
    Kim, Young Hak
    Mishima, Michiaki
    Yanagihara, Kazuhiro
    SUPPORTIVE CARE IN CANCER, 2013, 21 (12) : 3271 - 3278
  • [26] Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study
    Hiroki Nagai
    Toshiyuki Kitano
    Takafumi Nishimura
    Hiroyasu Yasuda
    Kazumi Nakata
    Sachie Takashima
    Masashi Kanai
    Shigemi Matsumoto
    Yukiko Mori
    Yuichi Kakudo
    Hiroyasu Sato
    Takuhiro Yamaguchi
    Kaoru Kameno
    Young Hak Kim
    Michiaki Mishima
    Kazuhiro Yanagihara
    Supportive Care in Cancer, 2013, 21 : 3271 - 3278
  • [27] Yacon syrup reduces postprandial glycemic response to breakfast: A randomized, crossover, double-blind clinical trial
    Adriano, Lia Silveira
    Dionisio, Ana Paula
    Pinto de Abreu, Fernando Antonio
    Ferreira Carioca, Antonio Augusto
    Zocolo, Guilherme Juliao
    Wurlitzer, Nedio Jair
    Pinto, Claudia de Oliveira
    de Oliveira, Ariclecio Cunha
    de Carvalho Sampaio, Helena Alves
    FOOD RESEARCH INTERNATIONAL, 2019, 126
  • [28] A Series of Personalized Virtual Light Therapy Interventions for Fatigue: Feasibility Randomized Crossover Trial for N-of-1 Treatment
    Butler, Mark
    DAngelo, Stefani
    Ahn, Heejoon
    Chandereng, Thevaa
    Miller, Danielle
    Perrin, Alexandra
    Romain, Anne-Marie N.
    Scatoni, Ava
    Friel, Ciaran P.
    Cheung, Ying-Kuen
    Davidson, Karina W.
    JMIR FORMATIVE RESEARCH, 2023, 7
  • [29] Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings
    Hesselink, Jan M. Keppel
    Kopsky, David J.
    Bhaskar, Arun K.
    JOURNAL OF PAIN RESEARCH, 2019, 12 : 345 - 352
  • [30] Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
    Kumarathurai, Preman
    Anholm, Christian
    Larsen, Bjorn S.
    Olsen, Rasmus Huan
    Madsbad, Sten
    Kristiansen, Ole
    Nielsen, Olav W.
    Haugaard, Steen B.
    Sajadieh, Ahmad
    DIABETES CARE, 2017, 40 (01) : 117 - 124